Elypta
elypta.comLocations
Solna, Sweden · Stockholm, Sweden · Stockholm, Sweden
Size
11-50 employees
Stage
Other
founded in
2017
Elypta is pioneering a metabolism-based liquid biopsy platform aimed at early cancer detection through noninvasive urine tests. Their flagship product, the Elypta MIRAM® Kit, leverages machine learning to analyze glycosaminoglycan profiles, potentially identifying cancer risks years before diagnosis. With significant traction, including a $1 million award from the Roddenberry Foundation and ISO 13485:2016 certification, Elypta is positioned as a leader in the early detection market, focusing on renal cell carcinoma and other cancer indications.
Something looks off?Open jobs at Elypta
This company does not have jobs relevant to this job board at this time.
To view all their jobs, visit their website.